CARBIOS has reduced its operating expenses and has a strong cash position of €72 million as of June 30, 2025, providing a cash horizon of more than 12 monthsThe Longlaville plant construction project ...

Grade Prices Thai RSS3 (October) 67.49 baht/kg Thai STR20 (October) 63.65 baht/kg Thai 60-percent latex (bulk/October) 43.93 baht/kg Malaysia SMR20 (October) $1.80/kg Indonesia SIR20 NA NOTE: Prices ...

The company behind hi tech beauty devices said to have been used by celebrities such as Kim Kardashian and Serena Williams ...

With two weeks to go until The World's 50 Best Bars 2025, sponsored by Perrier, the bars ranked from No.51 to No.100 have ...

Organized by China National Furniture Association & Shanghai Sinoexpo Informa Markets, the 30th edition of Furniture China (SNIEC, 09.10–13) and Maison Shanghai2025 (SWEECC, 09.09–12) held under the ...

Caught off guard by ChatGPT and mocked for early blunders with its own generative artificial intelligence efforts, Google has pulled off a dramatic turnaround in just one year, becoming a major player ...

I Am an Heir to Chinese Culture Talent Competition was staged at the Jinpinghu Grand Theatre inside the Pinghu Media Center. The event featured a program of vocal performances, dance, theater, and ...

North Sea-focused oil producer EnQuest maintained its full year production forecast on Wednesday after reporting a first-half loss after tax, partly hurt by Britain's windfall tax and declining output ...

Shipments of LTPO (Low-Temperature Polycrystalline Oxide) flexible AMOLEDs are expected to surpass those of LTPS ...

OCREVUS subcutaneous maintains consistent benefit-risk profile after two years New late-breaking data confirms OCREVUS ...

Seine, Wednesday, September 24, 2025 – 8.30 am ARGAN: S&P maintained the “Investment Grade” status with a “BBB-” rating and a “stable” outlook Following the press release1 indicating the withdrawal of ...

ARTIOS Phase IIIb, open-label, single-arm, prospective study showed a substantial reduction in disease activity in people with relapsing multiple sclerosis (RMS) following switch to Kesimpta after ...